Camargo Pharmaceutical names Jason Moore VP global program management
Camargo Pharmaceutical Services, a global strategist in the drug development industry specializing in the 505(b)(2) approval pathway, has appointed Jason Moore as vice president of global program management.
Moore will be responsible for enhancing Camargo’s project management process from proposals through project completion, which will be key to helping Camargo create the capacity to meet increasing client demand, according to Ken Phelps, Camargo president and CEO.
Moore brings more than 20 years of global drug development experience to Camargo, including specialized expertise ranging from enterprise project management and portfolio optimization to clinical studies and regulatory submissions, with extensive knowledge of the laws, regulations and guidances governing global drug development.
Previosuly, Moore was vice president at PLx Pharma for seven years, where he led all regulatory affairs functions and product submissions for five active investigational new drugs and one approved new drug application. He also held positions of increasing responsibility at organizations including BioHouston, Introgen and Agenus.